## **Core Concept**
The question tests the understanding of lung cancer types, specifically small cell lung cancer (SCLC) versus non-small cell lung cancer (NSCLC), and their typical presentations and characteristics. SCLC is a highly aggressive form of lung cancer strongly associated with smoking. It is known for rapid growth, early metastasis, and paraneoplastic syndromes.

## **Why the Correct Answer is Right**
The correct answer, , suggests that the presence of **ectopic ACTH production** (leading to Cushing's syndrome) is a feature of small cell lung cancer. SCLC can produce various ectopic hormones due to its neuroendocrine origin. Ectopic ACTH production is a well-documented paraneoplastic syndrome associated with SCLC, leading to Cushing's syndrome. This is characterized by weight gain (not loss, but can be seen in early stages), muscle weakness, thinning skin, and other symptoms, although weight loss can occur due to the cancer itself.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while **solitary pulmonary nodule** can be a presentation of lung cancer, it does not specifically suggest SCLC over NSCLC. Both types can present as a solitary nodule.
- **Option B:** This option is incorrect because **production of PTH-related protein** is more commonly associated with squamous cell carcinoma of the lung (a type of NSCLC), leading to hypercalcemia.
- **Option C:** This option is incorrect because **presence of a specific chromosomal translocation** might be seen in various cancers, but it does not specifically point towards SCLC. Some NSCLC have specific translocations.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **small cell lung cancer often presents with extensive disease at diagnosis** and is strongly associated with **paraneoplastic syndromes**, such as ectopic hormone production (e.g., ACTH, ADH), and **neuropathies**. Early metastasis and aggressive behavior are hallmarks, making it distinct from NSCLC.

## **Correct Answer: D. Ectopic ACTH production.**